Pathophysiology of modulation of local glucocorticoid levels by 11 β-hydroxysteroid dehydrogenases

Trends in Endocrinology and Metabolism

Volumn 12, Issue 10, 2001, Pages 446-453

  Sandeep, Thekkepat C ^a   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ANGIOTENSINAMIDE; GLUCOCORTICOID; HSD11B2 PROTEIN, HUMAN; HYDROXYSTEROID DEHYDROGENASE;

ANIMAL; ECTOPIC CORTICOTROPIN PRODUCTION; GENE DELETION; HUMAN; METABOLISM; OBESITY; PATHOPHYSIOLOGY; REVIEW; SYNDROME;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; 11-BETA-HYDROXYSTEROID DEHYDROGENASES; ACTH SYNDROME, ECTOPIC; ANGIOTENSIN AMIDE; ANIMALS; GENE DELETION; GLUCOCORTICOIDS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; OBESITY; SYNDROME;

EID: 0035656177     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(01)00499-4     Document Type: Review

References (77)

1. Stewart, P.M. and Sheppard, M.C. (1992) Novel aspects of hormone action: intracellular ligand supply and its control by a series of tissue specific enzymes. Mol. Cell. Endocrinol. 83, C13-C18
2. Amelung, D. et al. (1953) Conversion of cortisone to compound F. J. Clin. Endocrinol. Metab. 13, 1125-1128
3. Stewart, P.M. and Krozowski, Z.S. (1999) 11β-Hydroxysteroid dehydrogenase. Vitam. Horm. 57, 249-324
4. Seckl, J.R. and Walker, B.R. (2001) 11β-Hydroxysteroid dehydrogenase type 1 - a tissue specific amplifier of glucocorticoid action. Endocrinology 142, 1371-1376
5. White, P.C. et al. (1997) 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18, 135-156
6. Albiston, A.L. et al. (1994) Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105, R11-R17
7. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. Cloning and characterisation of cDNA from sheep kidney. J. Biol. Chem. 269, 25959-25962
8. Agarwal, A.K. et al. (1989) Cloning and expression of rat cDN A encoding corticosteroid 11β-dehydrogenase. J. Biol. Chem. 264, 18939-18943
9. Ulick, S. et al. (1979) A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of Cortisol. J. Clin. Endocrinol. Metab. 49, 757-764
10. Stewart, P.M. et al. (1987) Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2, 821-824
11. Funder, J.W. et al. (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242, 583-585
12. Edwards, C.R.W. et al. (1988) Localisation of 11β-hydroxysteroid dehydrogenase - tissue specific protector of the mineralocorticoid receptor. Lancet 2, 986-989
13. Arriza, J.L. et al. (1987) Cloning of human mineralocorticoid receptor complementary DNA; structural and functional kinship with the glucocorticoidreceptor. Science 237, 268-275
14. Kotelevtsev, Y.V. et al. (1997) 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid inducible responses and resist hyperglycaemia on obesity and stress. Proc. Natl. Acad. Sci. U. S. A. 94, 14924-14929
15. Kotelevtsev, Y.V. etal. (1999) Hypertension in mice caused by inactivation of 11β-hydroxysteroid dehydrogenase type 2. J. Clin. Invest. 103, 683-689
16. Waddell, B.J. et al. (1998) Tissue-specific messenger ribonucleic acid expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action. Endocrinology 139, 1517-1523
17. Stewart, P.M. et al. (1995) Type 2 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J. Clin. Endocrinol. Metab. 80, 885-890
18. Lindsay R.S. et al. (1996) Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11β-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39, 1299-1305
19. Lindsay, R.S. et al. (1996) Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27, 1200-1204
20. Brown, R. W. et al. (1996) The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137, 794-797
21. Stewart, P.M. et al. (1994) Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab. 78, 1529-1532
22. Walker, B.R. et al. (1992) Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin. Sci. 83, 171-178
23. Walker, B.R. et al. (1994) Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta. J. Hypertens. 12, 33-39
24. Brem, A.S. et al. (1997) Effects of licorice derivatives on vascular smooth muscle function. Life Sci. 60, 207-214
25. Finken, M.J.J. et al. (1999) Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductase but not 11-hydroxysteroid dehydrogenases. J. Clin. Endocrinol. Metab. 84, 3316-3321
26. Ricketts, M.L. et al. (1998) Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. J. Endocrinol. 156, 159-168
27. Moore, J.S. et al. (1999) Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 84, 4172-4177
28. Tomlinson, J.W. et al. (2001) Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue specific induction by cytokines. Endocrinology 142, 1982-1989
29. Jamieson, P.M. et al. (1995) 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136, 4754-4761
30. Jamieson, P.M. et al. (2000) 11β-Hydroxysteroid dehydrogenase type 1 is a predominant 11-reductase in the intact perfused rat liver. J. Endocrinol. 175, 685-692
31. Bujalska, I.J. et al. (1997) Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349, 1210-1213
32. Rajan, V. et al. (1996) 11β - Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity J. Neurosci. 16, 65-70
33. Brem, A.S. et al. (1995) Bidirectional activity of 11β - hydroxysteroid dehydrogenase in vascular smooth muscle cells. Steroids 60, 406-410
34. Ge, R-S. and Hardy, M.P. (2000) Initial predominance of the oxidative activity of type I 11β - hydroxysteroid dehydrogenase in primary rat Leydig cells and transfected cell lines. J. Androl. 21, 303-310
35. Leckie, C.M. et al. (1998) 11β - Hydroxysteroid dehydrogenase is a predominant reductase in intact rat Leydig cells. J. Endocrinol. 159, 233-238
36. Jamieson, P.M. et al. (1998) Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11β - hydroxysteroid dehydrogenase type 1. J. Endocrinol. 160, 103-109
37. Walker, B.R. et al. (1995) Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J. Clin. Endocrinol. Metab. 80, 3155-3159
38. Morton, N.M. et al. Improved lipid and lipoprotein profile, hepatic insulin sensitivity and glucose tolerance in 11β - hydroxysteroid dehydrogenase type 1 null mice. J. Biol. Chem. (in press)
39. Yang, K. et al. (1997) 11β - Hydroxysteroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J. Steroid Biochem. Mol. Biol. 60, 247-253
40. Bujalska, I.J. et al. (1999) Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β - hydroxysteroid dehydrogenases. Endocrinology 140, 3188-3196
41. Davani, B. et al. (2000) Type 1 11β-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. J. Biol. Chem. 275, 34841-34844
42. Moisan, M.P. et al. (1990) 11β-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: localization in hypothalamus, hippocampus and cortex. Endocrinology 127, 1450-1455
43. Sakai, R.R. et al. (1992) Immunocytochemical localization of 11β - hydroxysteroid dehydrogenase in hippocampus and other brain regions of the rat. J. Neuroendocrinol. 4, 101-106
44. Ajilore, O.A. and Sapolsky R.M. (1999) In vivo characterization of 11β - hydroxysteroid dehydrogenase in rat hippocampus using glucocorticoid neuroendangerment as an endpoint. Neuroendocrinology 69, 138-144
45. Yau, J.L.W. et al. (2001) Lack of tissue glucocorticoid reactivation in 11β-hydroxysteroid dehydrogenase type I knockout mice ameliorates age-related learning impairments. Proc. Natl. Acad. Sci. U. S. A. 98, 4716-4721
46. Harris, H.J. et al. (2001) Intracellularregeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase (11ß HSD)-I plays a key role in regulation of the hypothalamo-pituitary-adrenal axis: analysis of 11β-HSD 1 deficient mice. Endocrinology 142, 114-120
47. Dave-Sharma, S. et al. (1998) Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 83, 2244-2254
48. Palermo, M. et al. (1998) Cure of apparent mineral ocorticoid excess by kidney transplantation. New Engl. J. Med. 339, 1787-1788
49. Phillipou, G. et al. (1996) Apparent cortisone reductase deficiency; a unique form of hypercortisolism. J. Clin. Endocrinol. Metab. 81, 3855-3860
50. Jamieson, A. et al. (1999) Apparent cortisone reductase deficiency: a functional defect in 11β-hydroxysteroiddehydrogenasetype 1. J. Clin. Endocrinol. Metab. 84, 3570-3574
51. Rodin, A. et al. (1994) Hyperandrogenism in polycystic ovary syndrome: evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. New Engl. J. Med. 330, 460-465
52. Stewart, P.M. et al. (1999) Cortisol metabolism in human obesity: impaired cortisone-cortisol conversion in subjects with central adiposity. J. Clin. Endocrinol. Metab. 84, 1022-1027
53. Rask, E. et al. (2000) Tissue-specific dysregulation of cortisol metabolism in human obesity. J. Clin. Endocrinol. Metab. 86, 1418-1421
54. Strain, G.W. et al. (1982) Sex difference in the influence of obesity on the 24 hr mean plasma concentration of cortisol. Metabolism 31, 209-212
55. Andrew, R. et al. (1998) Obesity and gender influence cortisol secretion and metabolism in man. J. Clin. Endocrinol. Metab. 83, 1806-1809
56. Fraser, R. et al. (1999) Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension 33, 1364-1368
57. Livingstone, D.E.W. et al. (2000) Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 141, 560-563
58. Katz, J.R. et al. (1999) An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin. Endocrinol. 50, 63-68
59. Hammami, M.M. and Siiteri, P.K. (1991) Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. J. Clin. Endocrinol. Metab. 73, 326-334
60. Walker, B.R. (2000) How will we know if 11β-hydroxysteroid dehydrogenases are important in common diseases? Clin. Endocrinol. 52, 401-402
61. Kerstens, M.N. et al. (2000) Lack of relationship between 11β-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24 hour of insulin infusion in healthy subjects and type 2 diabetic patients. Clin. Endocrinol. 52, 403-411
62. Dullaart, R.B.F. et al. (1995) Alterations in cortisol metabolism in insulin-dependent diabetes mellitus: relationship with metabolic control and estimated blood volume and effect of angiotensin-converting enzyme inhibition. J. Clin. Endocrinol. Metab. 80, 3002-3008
63. Weaver, J.U. et al. (1998) Sexual dimorphism in 11βhydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects. Clin. Endocrinol. 49, 13-20
64. Davis, E.A. and Morris, D.J. (1991) Medicinal uses of licorice through the millennia: the good and plenty of it. Mol. Cell. Endocrinol. 78, 1-6
65. Iki, K. et al. (1994) The activities of 5β-reductase and 11β-hydroxysteroid dehydrogenase in essential hypertension. Steroids 59, 656-660
66. Soro, A. et al. (1995) Evidence of coexisting changes in 11β-hydroxysteroid dehydrogenase and 5β-reductase activity in patients with untreated essential hypertension. Hypertension 25, 67-70
67. Walker, B.R. et al. (1998) Increased glucocorticoid activity in men with cardiovascular risk factors. Hypertension 31, 891-895
68. Walker, B.R. et al. (1993) Deficient inactivation of cortisol by 11β-hydroxysteroid dehydrogenase in essential hypertension. Clin. Endocrinol. 39, 221-227
69. Lovati, E. et al. (1999) Molecular basis of human salt sensitivity : the role of the 11β-hydroxysteroid dehydrogenase type 2. J. Clin. Endocrinol. Metab. 84, 3745-3749
70. Takeda, Y. et al. (1994) Decreased activity of 11β-hydroxysteroid dehydrogenase in mesenteric arteries of Dahl salt-sensitive rats. Life Sci. 54, 1343-1349
71. Benediktsson, R. et al. (1993) Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341, 339-341
72. Benediktsson, R. et al. (1997) Placental 11β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin. Endocrinol. 46, 161-166
73. Rogerson, F.M. et al. (1997) Variation inplacental type 2 11β-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol. Cell. Endocrinol. 128, 103-109
74. Walker, B.R. et al. (1992) Mineralocorticoid excess and inhibition of 11βhydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin. Endocrinol. 27, 483-492
75. Ulick, S. et al. (1992) Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J. Clin. Endocrinol. Metab. 74, 963-967
76. Stewart, P.M. et al. (1995) 11β-Hydroxysteroid dehydrogenase activity in Gushing's syndrome: explaining the mineral ocorticoid excess state of the ectopic ACTH syndrome. J. Clin. Endocrinol. Metab. 80, 3617-3620
77. Diederich, S. et al. (1996) Human kidney 11β-hydroxysteroid dehydrogenase: regulation by adrenocorticotropin. Eur. J. Endocrinol. 134, 301-307